Ischemic Heart Disease
📧 Sign up to get email alerts when something new happens for Ischemic Heart Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-12-22FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for EFFIENT (prasugrel hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2020-12-15FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for the fixed-dose combination of amlodipine besylate and atorvastatin calcium, manufactured by …
-
FDA approval · 2020-11-25FDA Approved: METOPROLOL SUCCINATE — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories, LLC's metoprolol succinate extended-release tablets as an original application (generic).
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation [Phase 4]
A Phase 4 trial update comparing three vs twelve months of dual antiplatelet therapy after stent implantation.
-
FDA approval · 2020-06-24FDA Approved: AMMONIA N 13 — Supplemental Application (3D Imaging Drug Design and Development LLC)
FDA approved a supplemental application for AMMONIA N 13, a PET imaging radiopharmaceutical, submitted by 3D Imaging Drug Design and Develop…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: Growth Hormone in Ischemic Heart Failure [Phase 3]
Phase 3 clinical trial update evaluating growth hormone in ischemic heart failure has completed.
-
FDA approval · 2020-05-12FDA Approved: ISOSORBIDE DINITRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Isosorbide Dinitrate from Hikma Pharmaceuticals USA Inc., marking an approved modification t…
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: Efficacy of Long Term Plavix Therapy Post Angioplasty [NA]
A completed clinical trial investigating the efficacy of long-term Plavix (clopidogrel) therapy after angioplasty.
-
CLINICAL_TRIALS trial_result · 2020-02-25Clinical Trial Update: Cardiogoniometry for Detecting Coronary Artery Disease by CT Angiography [NA]
Clinical trial update for cardiogoniometry in detecting coronary artery disease using CT angiography; the study is terminated with posted re…
-
FDA approval · 2020-02-20FDA Approved: ISOSORBIDE DINITRATE — Supplemental Application (Sandoz Inc.)
The FDA approved a supplemental application for Isosorbide Dinitrate from Sandoz Inc., indicating regulatory approval of a change to the pro…
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Novel Adenosine-independent Index of Coronary Artery Stenosis Severity Resting Flow Reserve [NA]
A terminated clinical trial investigating an adenosine-independent index of coronary artery stenosis severity resting flow reserve; results …
-
FDA approval · 2020-02-05FDA Approved: TICAGRELOR — Supplemental Application (Hisun Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Ticagrelor from Hisun Pharmaceuticals USA, Inc., confirming approval of the generic ticagrel…
-
FDA approval · 2019-12-04FDA Approved: CARDIOLITE — Supplemental Application (Lantheus Medical Imaging, Inc.)
FDA approved a supplemental application for CARDIOLITE from Lantheus Medical Imaging, Inc., updating labeling and indications for the radiop…
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease [Phase 4]
Phase 4 clinical trial update on once versus twice daily administration of multiple cardiovascular agents in ischemic heart disease.
-
FDA approval · 2019-10-23FDA Approved: KENGREAL — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for KENGREAL (cangrelor) submitted by Chiesi USA, Inc., authorizing the changes included in the supp…
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up
A completed long-term clinical trial investigated how insulin sensitivity relates to cardiovascular risk markers over 10–20 years of follow-…
-
FDA approval · 2019-09-12FDA Approved: CLOPIDOGREL — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for clopidogrel from Amneal Pharmaceuticals LLC under ANDA 203751, confirming changes to the approve…
-
CLINICAL_TRIALS trial_result · 2019-08-30Clinical Trial Update: Cell Therapy in Severe Chronic Ischemic Heart Disease [Phase 3]
A Phase 3 trial update for a cell therapy in severe chronic ischemic heart disease has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Sequential Treatment of Extra-Corporeal Shock Wave Combined With aUtologous Bone marRow Mesenchymal Stem Cells on Patients With ischEmic Heart Disease : the S-CURE Study [Phase 1, Phase 2]
A clinical trial update on sequential treatment using extracorporeal shock wave therapy plus autologous bone marrow mesenchymal stem cells f…
-
FDA label_change · 2019-08-07FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Bisoprolol Fumarate by Unichem Pharmaceuticals (USA), Inc., resulting in a labeling change for t…
-
FDA approval · 2019-08-02FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories' supplemental application for clopidogrel bisulfate, approving changes to the product's labeling.
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions [NA]
A completed clinical trial evaluating the safety and effectiveness of the Orsiro sirolimus-eluting coronary stent system in subjects with co…
-
CLINICAL_TRIALS trial_result · 2019-07-22Clinical Trial Update: XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)
Post-marketing trial update for XIENCE PRIME SV Everolimus-eluting coronary stent in Japan shows completion with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Sustaining Physical Activity Following Cardiac Rehabilitation Completion [NA]
A completed clinical trial evaluating strategies to sustain physical activity after cardiac rehabilitation completion.
-
FDA approval · 2019-04-26FDA Approved: CARDIOGEN-82 — Supplemental Application (Bracco Diagnostics Inc)
The FDA approved a supplemental application for CardioGen-82 (rubidium-82 chloride) submitted by Bracco Diagnostics Inc.